Viewing Study NCT04509193


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2025-12-29 @ 8:09 PM
Study NCT ID: NCT04509193
Status: COMPLETED
Last Update Posted: 2022-06-15
First Post: 2020-08-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-08-21
Start Date Type: ACTUAL
Primary Completion Date: 2021-07-31
Primary Completion Date Type: ACTUAL
Completion Date: 2021-07-31
Completion Date Type: ACTUAL
First Submit Date: 2020-08-10
First Submit QC Date: None
Study First Post Date: 2020-08-11
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-06-13
Last Update Post Date: 2022-06-15
Last Update Post Date Type: ACTUAL